What physicians and health organizations should know about mandated imaging appropriate use criteria

Keith D. Hentel, Andrew Menard, John Mongan, Jeremy C. Durack, Pamela Johnson, Ali S. Raja, Ramin Khorasani

Research output: Contribution to journalArticle

Abstract

The Appropriate Use Criteria Program, enacted by the Centers for Medicare & Medicaid Services in response to the Protecting Access to Medicare Act of 2014 (PAMA), aims to reduce inappropriate and unnecessary imaging by mandating use of clinical decision support (CDS) by all providers who order advanced imaging examinations (magnetic resonance imaging; computed tomography; and nuclear medicine studies, including positron emission tomography). Beginning 1 January 2020, documentation of an interaction with a certified CDS system using approved appropriate use criteria will be required on all Medicare claims for advanced imaging in all emergency department patients and outpatients as a prerequisite for payment. The Appropriate Use Criteria Program will initially cover 8 priority clinical areas, including several (such as headache and low back pain) commonly encountered by internal medicine providers. All providers and organizations that order and provide advanced imaging must understand program requirements and their options for compliance strategies. Substantial resources and planning will be needed to comply with PAMA regulations and avoid unintended negative consequences on workflow and payments. However, robust evidence supporting the desired outcome of reducing inappropriate use of advanced imaging is lacking.

Original languageEnglish (US)
Pages (from-to)880-885
Number of pages6
JournalAnnals of internal medicine
Volume170
Issue number12
DOIs
StatePublished - Jun 18 2019

Fingerprint

Medicare
Clinical Decision Support Systems
Organizations
Physicians
Health
Workflow
Nuclear Medicine
Medicaid
Internal Medicine
Low Back Pain
Documentation
Positron-Emission Tomography
Compliance
Headache
Hospital Emergency Service
Outpatients
Tomography
Magnetic Resonance Imaging

ASJC Scopus subject areas

  • Internal Medicine

Cite this

What physicians and health organizations should know about mandated imaging appropriate use criteria. / Hentel, Keith D.; Menard, Andrew; Mongan, John; Durack, Jeremy C.; Johnson, Pamela; Raja, Ali S.; Khorasani, Ramin.

In: Annals of internal medicine, Vol. 170, No. 12, 18.06.2019, p. 880-885.

Research output: Contribution to journalArticle

Hentel, Keith D. ; Menard, Andrew ; Mongan, John ; Durack, Jeremy C. ; Johnson, Pamela ; Raja, Ali S. ; Khorasani, Ramin. / What physicians and health organizations should know about mandated imaging appropriate use criteria. In: Annals of internal medicine. 2019 ; Vol. 170, No. 12. pp. 880-885.
@article{45f2d3c77baa4b4285a11f76fd716a6f,
title = "What physicians and health organizations should know about mandated imaging appropriate use criteria",
abstract = "The Appropriate Use Criteria Program, enacted by the Centers for Medicare & Medicaid Services in response to the Protecting Access to Medicare Act of 2014 (PAMA), aims to reduce inappropriate and unnecessary imaging by mandating use of clinical decision support (CDS) by all providers who order advanced imaging examinations (magnetic resonance imaging; computed tomography; and nuclear medicine studies, including positron emission tomography). Beginning 1 January 2020, documentation of an interaction with a certified CDS system using approved appropriate use criteria will be required on all Medicare claims for advanced imaging in all emergency department patients and outpatients as a prerequisite for payment. The Appropriate Use Criteria Program will initially cover 8 priority clinical areas, including several (such as headache and low back pain) commonly encountered by internal medicine providers. All providers and organizations that order and provide advanced imaging must understand program requirements and their options for compliance strategies. Substantial resources and planning will be needed to comply with PAMA regulations and avoid unintended negative consequences on workflow and payments. However, robust evidence supporting the desired outcome of reducing inappropriate use of advanced imaging is lacking.",
author = "Hentel, {Keith D.} and Andrew Menard and John Mongan and Durack, {Jeremy C.} and Pamela Johnson and Raja, {Ali S.} and Ramin Khorasani",
year = "2019",
month = "6",
day = "18",
doi = "10.7326/M19-0287",
language = "English (US)",
volume = "170",
pages = "880--885",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "12",

}

TY - JOUR

T1 - What physicians and health organizations should know about mandated imaging appropriate use criteria

AU - Hentel, Keith D.

AU - Menard, Andrew

AU - Mongan, John

AU - Durack, Jeremy C.

AU - Johnson, Pamela

AU - Raja, Ali S.

AU - Khorasani, Ramin

PY - 2019/6/18

Y1 - 2019/6/18

N2 - The Appropriate Use Criteria Program, enacted by the Centers for Medicare & Medicaid Services in response to the Protecting Access to Medicare Act of 2014 (PAMA), aims to reduce inappropriate and unnecessary imaging by mandating use of clinical decision support (CDS) by all providers who order advanced imaging examinations (magnetic resonance imaging; computed tomography; and nuclear medicine studies, including positron emission tomography). Beginning 1 January 2020, documentation of an interaction with a certified CDS system using approved appropriate use criteria will be required on all Medicare claims for advanced imaging in all emergency department patients and outpatients as a prerequisite for payment. The Appropriate Use Criteria Program will initially cover 8 priority clinical areas, including several (such as headache and low back pain) commonly encountered by internal medicine providers. All providers and organizations that order and provide advanced imaging must understand program requirements and their options for compliance strategies. Substantial resources and planning will be needed to comply with PAMA regulations and avoid unintended negative consequences on workflow and payments. However, robust evidence supporting the desired outcome of reducing inappropriate use of advanced imaging is lacking.

AB - The Appropriate Use Criteria Program, enacted by the Centers for Medicare & Medicaid Services in response to the Protecting Access to Medicare Act of 2014 (PAMA), aims to reduce inappropriate and unnecessary imaging by mandating use of clinical decision support (CDS) by all providers who order advanced imaging examinations (magnetic resonance imaging; computed tomography; and nuclear medicine studies, including positron emission tomography). Beginning 1 January 2020, documentation of an interaction with a certified CDS system using approved appropriate use criteria will be required on all Medicare claims for advanced imaging in all emergency department patients and outpatients as a prerequisite for payment. The Appropriate Use Criteria Program will initially cover 8 priority clinical areas, including several (such as headache and low back pain) commonly encountered by internal medicine providers. All providers and organizations that order and provide advanced imaging must understand program requirements and their options for compliance strategies. Substantial resources and planning will be needed to comply with PAMA regulations and avoid unintended negative consequences on workflow and payments. However, robust evidence supporting the desired outcome of reducing inappropriate use of advanced imaging is lacking.

UR - http://www.scopus.com/inward/record.url?scp=85067572048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067572048&partnerID=8YFLogxK

U2 - 10.7326/M19-0287

DO - 10.7326/M19-0287

M3 - Article

VL - 170

SP - 880

EP - 885

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 12

ER -